Literature DB >> 23960085

New oral anticoagulants in heart failure.

Isabelle C Van Gelder, Dirk J Van Veldhuisen, Gregory Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23960085     DOI： 10.1093/eurjhf/hft135

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  2 in total

1.  What should the C ('congestive heart failure') represent in the CHA2 DS2 -VASc score?

Authors:  Bart A Mulder; Dirk J van Veldhuisen; Michiel Rienstra
Journal:  Eur J Heart Fail       Date:  2020-07-22       Impact factor: 15.534

2.  Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial.

Authors:  Faiez Zannad; Barry Greenberg; John G F Cleland; Mihai Gheorghiade; Dirk J van Veldhuisen; Mandeep R Mehra; Stefan D Anker; William M Byra; Min Fu; Roger M Mills
Journal:  Eur J Heart Fail       Date:  2015-04-27       Impact factor: 15.534
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.